Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin, 1 gram fits all?
NL-OMON31576Recruiting
- Sponsor
- Erasmus MC
- Start
- Apr 2008
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of cefazolin in surgical site infection (SSI), sponsored by Erasmus MC. Primary endpoints: Cefazolin plasma concentrations and Cefazolin interstitial fluid concentrations. Started Apr 2008; status: recruiting.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NL-OMON31576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31576.